JP Morgan Chase
DRUG

JP Morgan Chase’s Bright Minds Biosciences DRUG Stock Holding History

JP Morgan Chase’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$331K Buy
4,778
+901
+23% +$70.7K ﹤0.01% 5339
2026
Q1 		$265K Buy
3,877
+1,361
+54% +$110K ﹤0.01% 5331
2025
Q4 		$196K Sell
2,516
-2,749
-52% -$184K ﹤0.01% 5555
2025
Q3 		$319K Buy
5,265
+3,092
+142% +$120K ﹤0.01% 5269
2025
Q2 		$17.3K Buy
2,173
+1,873
+624% +$56.2K ﹤0.01% 6207
2025
Q1 		$2.39K Buy
+300
New +$11K ﹤0.01% 6522

Other funds holding DRUG

JT
Jupiter Topco New York $245B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

JP Morgan Chase's DRUG Position: Q2 2026 in Review

JP Morgan Chase increased its Bright Minds Biosciences (DRUG) stake by 23% in Q2 2026, buying an estimated $70.7K and bringing the position to 4,778 shares worth $331K. The position accounts for ﹤0.01% of the portfolio, ranked #5339.

JP Morgan Chase first reported a position in DRUG in Q1 2025 and has held it in 6 quarters since. 100 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • JP Morgan Chase held 4,778 shares of Bright Minds Biosciences worth $331K as of Q2 2026.
  • JP Morgan Chase bought 901 Bright Minds Biosciences shares in Q2 2026, an estimated $70.7K.
  • Bright Minds Biosciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5339 holding.
  • JP Morgan Chase first reported a position in Bright Minds Biosciences in Q1 2025 and has held it in 6 quarters since.
  • 100 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.